Life

In the Life organization, we established the business vision "We will lead the world in advancing Bio Industrial Autonomy and contribute to a future embracing global harmony" with the aim of clarifying future developments of the business, its scope and direction. In this vision, we have targeted the "Pharmaceutical, Food, Beverage & Biotech" sectors and aim to further expand our business, centering on these industries, by taking advantage of our strengths in "Measurement, Imaging, Analysis, Diagnosis, Integration" and Yokogawa core technologies.

 


Solutions to Achieve Well-being

Life Science

By contributing to the development of measurement and analysis technologies, we will solve problems that limit research progress and create a world where scientists can concentrate on science.

Bioprocess

Using real-time monitoring and software innovations, we will create a virtual world of "Digital Twin" where experimental simulations are leveraged  to realize precision predictive control

Pharmaceutical

We analyze and control the information obtained from all manufacturing activities and solve issues related to raw material quality, facility degradation, transmission of technology, and production processes to improve work environment and worker safety.

Food&Beverage

In addition to improving optimal and efficient automatic processes based on demand forecasting, we will assist with quality improvements that include taste attributes, and promote autonomous operation that grows independent of human intervention.
 

Water & Wastewater

Yokogawa supports a wide range of water control applications in both the municipal and industrial water markets.

  • Life Science

    We have 30 years of experience in this life science field and will respond to customer's problem solving with cutting-edge solutions.

    See More
  • Solutions for Single-cell Analysis

    YOKOGAWA is working on the development of single cell mass spectrometry and single cell gene analysis.  In order to analyze one cell with high sensitivity, we are developing a method of collecting target cells while keeping position information under observing cells with confocal scanner.

    See More
  • Solutions for Pharmaceutical

    Yokogawa is contributing to the development of the pharmaceutical industry based on its performance of introducing over 1,000 systems in the areas of drug substances, pharmaceutical products, and biotechnology.

    See More
  • Solutions for Food & Beverage

    In addition to daily improvement cycles, Yokogawa will use IIoT to support create environments that do not cause defects and that are designed to completely reduce losses.

    See More

Details

Life Business Headquarters’ contribution towards the fight against Novel Coronavirus Disease (COVID-19)

Yokogawa established the Life Business Headquarters with the goal of promoting well-being for all. In addition to engaging in our existing life science and manufacturing solutions businesses targeting the pharmaceutical and food industries, the headquarters works to develop new products and services and provides one-stop solutions that revolutionize productivity throughout the pharmaceutical and food industry value chain, from basic research to manufacturing, logistics, and services.

Yokogawa has more than 30 years’ experience in the life science field. The CSU spinning disk confocal scanner series is our core strength, and over 3,000 units have been sold globally. Other products, including a live cell imaging system, a high-content analysis system and single cell analysis solution also support leading life science studies. In the field of manufacturing solutions, over 1,000 Yokogawa manufacturing, production, and quality management systems and control systems have been introduced in the pharmaceutical industry.

In response to the novel coronavirus (COVID-19), Yokogawa has been taking various measures to prevent transmission of the virus while working to minimize the impact on customers. We are also contributing to the fight against COVID-19 by collaborating with research institutes globally and supporting research to develop new medication or vaccines. Yokogawa will continue to work with customers and business partners in an effort to resolve the crisis society is facing.

Please contact our sales and service representatives if you have any interest in our products, or you can send inquiries from the form below.

January 8,2021

Sales release : Advanced Control Bioreactor System BR1000 was released.
The Advanced Control Bioreactor System BR1000 automates lab-scale mammalian cell culture with highly accurate real-time monitoring and advanced process control.

Click Here For More Info 

October 23,2020

YOKOGAWA Sponsored Webinar
November 24, 2020 3:00 pm to 4:00 pm JST
(11:30 am to 12:30 pm India/ 2:00 pm to 3:00 pm SGT)

Abstract:
Process control for mammalian cell culture is cutting-edge with Yokogawa’s lab-scale advanced control bioreactor system.
In-line sensing and cell model derivation has never been easier or more accurate.
Driven by innovative model predictive control, the dynamic feeding of glucose results in overall productivity and product quality gains.

Click Here for Registration

August 21,2020

Bioprocessing Summit 2020 Virtual

Dates: August 24-28 EST, 2020
Location: Virtual Event

Yokogawa introduce about advanced automated bioreactor controller system. Join us at our virtual tradeshow booth. We look forward to connecting with you.

Click Here For Registration

August 20,2020

Discovering Potential Covid-19 Therapies using High Content Screening

Date: Wednesday August 26th 2020
Time: 12pm (EST) 9am (PST) 5pm (London)

Abstract:
In this webinar, Professor Jonny Sexton discusses a pipeline, developed in the Sexton lab, for the quantitative high-throughput image-based screening of SARS-CoV-2 infection to identify potential antiviral mechanisms and allow selection of appropriate drug combinations to treat COVID-19. This webinar presents evidence that morphological profiling can robustly identify new potential therapeutics against SARS-CoV-2 infection as well as drugs that potentially worsen COVID-19 outcomes.

Click Here for  Registration

June 22,2020

YOKOGAWA Sponsored Webinar

July 29, 2020 11 am to 12 pm EDT (July 30, 2020 0 am to 1 am JST)

Integration of soft-sensor technologies with CHO-cell predictive models for improved bioreactor automation & process control

Abstract:
Process control for mammalian cell culture is cutting-edge with Yokogawa’s lab-scale advanced control bioreactor system.  In-line sensing and cell model derivation has never been easier or more accurate.  Driven by innovative model predictive control, the dynamic feeding of glucose results in overall productivity and product quality gains.  And the same cell model and automation concept can also be applied to biopharmaceutical product manufacturing.

Click Here for Registration

June 5,2020

BIO Digital 2020

June 8-12, 2020
Virtual Event
Click Here For More Info

We will participate in partnering event and hold a corporate seminar about Advanced Control Bioreactor System.

We post our information to the following SNSs.
Please follow us.

Yokogawa Life Science

•Twitter @Yokogawa_LS
•Facebook Yokogawa Life Science
•LinkedIn Yokogawa Life Science

Yokogawa's Official Social Media Account List

Social Media Account List

Resources

Overview:

A critical requirement in biopharmaceutical development is the integration and automation of process equipment and analytical instruments used in the laboratory. Bioprocess labs with multiple lab-scale bioreactors often execute cultivation experiments in parallel for research or process development purposes.

As part of a collaboration between Securecell (Zurich, SW) and Yokogawa Life Science (Tokyo, Japan), this application note demonstrates the effective use of the Lucullus® Process Information Management System (Lucullus®) to assist in the control of three Advanced Control Bioreactor Systems (BR1000) to study glucose utilization of CHO cells for optimal monoclonal antibody productivity.

Industries:
Overview:

Exploring the technologies needed to achieve automatic control of cell culture processes.

Industries:

Downloads

Videos

Overview:

In this webinar, Professor Jonny Sexton discusses a pipeline, developed in the Sexton lab, for the quantitative high-throughput image-based screening of SARS-CoV-2 infection to identify potential antiviral mechanisms and allow selection of appropriate drug combinations to treat COVID-19. This webinar presents evidence that morphological profiling can robustly identify new potential therapeutics against SARS-CoV-2 infection as well as drugs that potentially worsen COVID-19 outcomes.

News

Looking for more information on our people, technology and solutions?

Contact Us

Top